Evidence map›Paper›PMID 28827767›Full record

ArticleScientific reports2017

Temporal trends in Prevalence, Awareness, Treatment, and Control of Hypertension from 2000 to 2010 in Chengdu, China.

Gang Huang, Jun-Bo Xu, Ya Liu, Zhao-Hui Liu, Yun-Lan Zhang, Yue-Lei Wu, Rui-Lian Wen, Shi Zhu, Ting-Jie Zhang

Abstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Trends of Status of Hypertension in Southern China, 2012-2019.International journal of general medicine · 2020
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Gang HuangCardiovascular and Metabolic Disease Center, The Second People's Hospital of Chengdu, Chengdu, China. oigg1982@gmail.com.
Jun-Bo XuCardiovascular and Metabolic Disease Center, The Second People's Hospital of Chengdu, Chengdu, China.
Ya LiuCardiovascular and Metabolic Disease Center, The Second People's Hospital of Chengdu, Chengdu, China.
Zhao-Hui LiuCardiovascular and Metabolic Disease Center, The Second People's Hospital of Chengdu, Chengdu, China.
Yun-Lan ZhangCardiovascular and Metabolic Disease Center, The Second People's Hospital of Chengdu, Chengdu, China.
Yue-Lei WuDepartment of Cardiology, The First People's Hospital of Chengdu, Chengdu, China.
Rui-Lian WenCardiovascular and Metabolic Disease Center, The Second People's Hospital of Chengdu, Chengdu, China.
Shi ZhuDepartment of Cardiology, The First People's Hospital of Chengdu, Chengdu, China.
Ting-Jie ZhangCardiovascular and Metabolic Disease Center, The Second People's Hospital of Chengdu, Chengdu, China. zhangtj1934@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to describe trends in prevalence, awareness, treatment, and control in hypertension in Chengdu from 2000 to 2010. Two community-based cross sectional surveys were conducted among those aged 40-79 years in 2000 (n = 4850) and 2010 (n = 5456). Demographic characteristics, blood pressure (BP) and associated risk factors were examined. Mean systolic and diastolic BP increased from 117.8 ± 33.9 to 132.1 ± 21.2 mmHg (P < 0.001), and 75.3 ± 19.1 to 79.3 ± 11.2 mmHg (P < 0.001) over past decade, respectively. The prevalence of hypertension increased from 27.7 to 29.4% (P < 0.001). Awareness increased from 37.7 to 42.5% (P < 0.001). The overall treatment rate increased from 20.9 to 28.0% (P < 0.0001), while among subjects aware of hypertension, treatment increased from 46.9 to 65.8% (P < 0.001). In hypertensives, control increased from 6.8 to 6.9% (P = 0.6684). Nevertheless, in hypertensives aware and treated, control decreased from 32.5 to 24.3% (P = 0.020). Hypertension prevalence increased in the last decade, while awareness, treatment and control remained considerably low in Chengdu.

Indexed as

Health Knowledge, Attitudes, PracticeAdultAgedAntihypertensive AgentsChinaCross-Sectional StudiesFemaleHumansHypertensionMaleMiddle AgedPrevalenceRisk FactorsAntihypertensive Agents

Identifiers

PMID28827767
PMCPMC5566432

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.